- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05909384
Management of Sepsis in Resource Limited Settings Using a Delphi Method.
January 17, 2024 updated by: Oxford University Clinical Research Unit, Vietnam
Expert Consensus Statements for the Management of Sepsis in Resource Limited Settings Using a Delphi Method
Rapid evolution of sepsis syndromes means that timely diagnosis and treatment are critical in improving outcomes but this may be difficult to achieve in many low- and middle- income countries (LMICs) and there is a lack of high quality clinical evidence to guide diagnosis and management in LMIC settings.
The wide variability in health systems in LMICs means that additional areas of guidance may be required where staff or facilities are lacking.
In the absence of clinical data, to address some of these issues, the investigators aim to use Delphi methodology to obtain experts consensus statements on some specific aspects of sepsis management in LMICs.
Study Overview
Detailed Description
The investigators aim to use a Delphi process to generate expert consensus practice statements in the context of diagnosis and management of sepsis in LMICs, including identification of aspects of sepsis diagnosis and management in LMICs not covered by existing guidelines.
The questions will undergo several iterative rounds and will be in multiple-choice or Likert scale format.
A study steering group will review the results of each round via video conference and design the questionnaire for the next survey.
Summary results of each round will be presented to experts, along with the survey questionnaire for the next round.
The survey process will be repeated with the modified questionnaire.
The Delphi rounds will continue until the desired consensus and stability are achieved.
Study Type
Observational
Enrollment (Actual)
36
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ho Chi Minh City, Vietnam
- Oxford University Clinical Research Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Participants will be recognized experts meeting pre-defined criteria from a wide geographical distribution with approximately 70% from LMICs
Description
Inclusion Criteria:
Recognized experts meeting pre-defined criteria (below) from a wide geographical distribution with approximately 70% from LMICs.
- Clinical expertise in adult sepsis management, AND
Demonstrated involvement with sepsis related research, educations, policy/protocols, professional activities
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Expert group
|
Multiple rounds of surveys collecting information on sepsis diagnosis and management in resource-limited settings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire statements which have reached pre-defined consensus
Time Frame: 2 weeks
|
Descriptive analysis of questionnaire statements which have reached pre-defined consensus.
Consensus will be defined as >70% participants in favour of agree/disagree statements (Likert scale 1-3 means disagree or 5-7 means agree), or >80% in favour of single option in a single stem question with multiple responses (yes/no answers).
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: Brett Abbenbroek, BSc,MPH,PhD, The George Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 16, 2023
Primary Completion (Actual)
August 21, 2023
Study Completion (Actual)
September 30, 2023
Study Registration Dates
First Submitted
May 19, 2023
First Submitted That Met QC Criteria
June 8, 2023
First Posted (Actual)
June 18, 2023
Study Record Updates
Last Update Posted (Estimated)
January 19, 2024
Last Update Submitted That Met QC Criteria
January 17, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APSADelphi_V1.2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.